Yayınlar & Eserler

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Sequencing novel agents in the treatment of classical hodgkin lymphoma.

Ferhanoglu B., Özbalak M. M.
Expert review of hematology , 2023 (SCI-Expanded) identifier

Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data

Atesoglu E. B., Gulbas Z., UZAY A., ÖZCAN M., ÖZKALEMKAŞ F., Dal M. S., et al.
HEMATOLOGICAL ONCOLOGY , cilt.41, sa.4, ss.663-673, 2023 (SCI-Expanded) identifier identifier identifier

Independent risk factors for COVID-19-associated coagulopathy.

Tor Y., Ozbalak M. M., Kalayoglu-Besisik S., Aksoy E., Cagatay A., Gul A., et al.
European review for medical and pharmacological sciences , cilt.27, sa.16, ss.7851-7860, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience

Özbalak M. M., Güzel Mastanzade M., Özlük Ö., Tiryaki T. O., Erdem S., Özbalak E. P., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.39, sa.4, ss.254-261, 2022 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier identifier

Overview of clinical and genetic features of CML patients with variant Philadelphia translocations involving chromosome 7: A case series

Bayrak A. G., Daglar Aday A., Yavuz A. S., Nalcaci M., Ozbalak M. M., Cefle K., et al.
LEUKEMIA RESEARCH , cilt.111, 2021 (SCI-Expanded) identifier identifier identifier

Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study.

Akay O. M., Ozbalak M. M., Pehlivan M., Yildiz B., Uzay A., Yigenoglu T. N., et al.
Hematological oncology , cilt.39, sa.4, ss.498-505, 2021 (SCI-Expanded) identifier identifier identifier

Raman tweezers as an alternative diagnostic tool for paroxysmal nocturnal hemoglobinuria.

Soysal K. B., Parlatan S., Mastanzade M., Ozbalak M. M., Yenerel M. N., ÜNLÜ M. B., et al.
Analytical methods : advancing methods and applications , cilt.13, sa.35, ss.3963-3969, 2021 (SCI-Expanded) identifier identifier identifier

Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

Ozbalak M. M., Akay O. M., PEHLİVAN M., Yildiz B., UZAY A., Yigenoglu T. N., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.21, 2021 (SCI-Expanded) identifier

Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience

Bekoz H., ÖZBALAK M. M., Karadurmus N., PAYDAŞ S., Turker A., TOPTAŞ T., et al.
ANNALS OF HEMATOLOGY , cilt.99, sa.11, ss.2565-2576, 2020 (SCI-Expanded) identifier identifier identifier

Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience.

Ozbalak M. M., SALİHOĞLU A., Soysal T., Karadogan I., PAYDAŞ S., Ozdemir E., et al.
Annals of hematology , cilt.99, sa.2, ss.301-307, 2020 (SCI-Expanded) identifier identifier identifier

Venetoclax-Rituximab in Chronic Lymphocytic Leukemia

Ferhanoglu B., Ozturk E., ÖZBALAK M. M.
NEW ENGLAND JOURNAL OF MEDICINE , cilt.378, sa.22, ss.2141-2143, 2018 (SCI-Expanded) Creative Commons License identifier identifier identifier

Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.

Bekoz H., Karadurmus N., Paydas S., Turker A., Toptas T., Tuglular T. F., et al.
Annals of oncology : official journal of the European Society for Medical Oncology , cilt.28, sa.10, ss.2496-2502, 2017 (SCI-Expanded) identifier identifier identifier

Use of fluorodeoxyglucose positron emission tomography for diagnosis of bleomycin-induced pneumonitis in Hodgkin lymphoma

Falay O., Ozturk E., Bolukbasi Y., Gumus T., Ornek S., ÖZBALAK M. M., et al.
LEUKEMIA & LYMPHOMA , cilt.58, sa.5, ss.1114-1122, 2017 (SCI-Expanded) identifier identifier identifier

Comparison of International Prognostic Index and NCCN-IPI in 324 patients with de novo diffuse large B-cell lymphoma: a multi-center retrospective analysis.

ÖZTÜRK E., ÖZBALAK M. M., Berk S., Erdoğan I., AVŞAR E., DOLGUN A., et al.
Leukemia & lymphoma , cilt.57, ss.1211-4, 2016 (SCI-Expanded) identifier identifier identifier

Is valganciclovir really effective in primary effusion lymphoma: case report of an HIV(-) EBV(-) HHV8(+) patient.

Ozbalak M. M., TOKATLI I., Ozdemirli M., Tecimer T., Ar M. C., ORNEK S., et al.
European journal of haematology , cilt.91, sa.5, ss.467-9, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

An unusual presentation of a chronic lymphocytic leukemia patient with 17p deletion after reduced-intensity transplantation: Richter syndrome and concomitant graft-versus-host disease--case report.

Salihoglu A., Ozbalak M. M., Keskin D., Tecimer T., Soysal T., Ferhanoglu B.
Transplantation proceedings , cilt.45, sa.7, ss.2845-8, 2013 (SCI-Expanded) identifier identifier identifier

Azacitidine has limited activity in 'real life' patients with MDS and AML: a single centre experience.

Ozbalak M. M., Cetiner M., Bekoz H., Atesoglu E. B., Ar C., Salihoglu A., et al.
Hematological oncology , cilt.30, sa.2, ss.76-81, 2012 (SCI-Expanded) identifier identifier identifier

Severe bone marrow failure due to valganciclovir overdose after renal transplantation from cadaveric donors: four consecutive cases.

Ar M. C., Ozbalak M. M., Tuzuner N., Bekoz H., Ozer O., Ugurlu K., et al.
Transplantation proceedings , cilt.41, sa.5, ss.1648-53, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Prognostic significance of micro vessel density in diffuse large B cell lymphomas

Soer M., Ozbalak M. M., Senocak M., Soysal T., Ferhanoglu B., Molinas N., et al.
VIRCHOWS ARCHIV , cilt.451, sa.2, ss.357-358, 2007 (SCI-Expanded) identifier

Primary cutaneous T-cell lymphomas other than mycosis fungoides and primary cutaneous CD30(+) lymphoproliferative disorders

Ozbalak M. M., Demirkesen C., Oguz O., Onsun N., Tuzuner N.
VIRCHOWS ARCHIV , cilt.451, sa.2, ss.456, 2007 (SCI-Expanded) identifier

Diğer Dergilerde Yayınlanan Makaleler

Central nervous system involvement of mantle cell lymphoma: Case report and review of the literature

Ağargün B. F., Yegen G., Özbalak M. M., Gülseren Ü. A.
Hematology, Transfusion and Cell Therapy , cilt.1, sa.1, ss.1, 2022 (ESCI)

Salvage Intrapartum Splenectomy for the Treatment of Transfusion-refractory Anaemia in a ß-thalassemia Intermedia Patient

Saraç Sivrikoz T., Özbalak M. M., Tükenmez M., Beşışık S.
Journal of College of Physicians and Surgeons Pakistan , cilt.32, sa.10, ss.1344-1346, 2022 (Hakemli Dergi)

Dipyridamole does not have any additive effect on the prevention of COVID-19 coagulopathy.

Kalayoglu Besisik S., Ozbalak M. M., Tor Y. B., Medetalibeyoglu A., Kose M., Senkal N., et al.
American journal of blood research , cilt.12, sa.2, ss.54-59, 2022 (Hakemli Dergi) Sürdürülebilir Kalkınma identifier

R-CHOP Chemotherapy with a Rituximab Biosimilar (Redditux®) for Patients with de novo Diffuse Large B-cell Lymphoma: First Preliminary Results of a Real-Life Single-Center Experience from Turkey

Özbalak M. M., Mastanzade M., Özlük Ö., Tiryaki T. O., Pınar Özbalak E., Yönal Hindilerden İ., et al.
İstanbul Kanuni Sultan Süleyman Tıp Dergisi , cilt.13, sa.3, ss.194-198, 2021 (Hakemli Dergi)

KILLER IMMUNOGLOBULINE LIKE RECEPTOR GENE ANALYSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND ITS RELATION WITH AUTOIMMUNITY

Ozbalak M. M., Ozunal I. E., Berk S., ELVERDİ T., SALİHOĞLU A., EŞKAZAN A. E., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.84, sa.2, ss.227-236, 2021 (ESCI) identifier identifier

Initial complete blood count score and predicting disease progression in COVID-19 patients.

Ozbalak M. M., Kalayoglu Besisik S., Tor Y. B., Medetalibeyoglu A., Kose M., Senkal N., et al.
American journal of blood research , cilt.11, sa.1, ss.77-83, 2021 (ESCI) Sürdürülebilir Kalkınma identifier

Cytomegalovirus reactivation during adult acute lymphoblastic leukemia maintenance: do we underestimate (un)expected guest of pediatric approach?

Ozbalak M. M., Mastanzade M., GÜREL E., BEŞIŞIK S.
AMERICAN JOURNAL OF BLOOD RESEARCH , cilt.11, sa.1, ss.118-122, 2021 (ESCI) Sürdürülebilir Kalkınma identifier

Initial complete blood count score and predicting disease progression in COVID-19 patients

Ozbalak M. M., Besisik S., Tor Y. B., Medetalibeyoglu A., Kose M., Senkal N., et al.
AMERICAN JOURNAL OF BLOOD RESEARCH , cilt.11, sa.1, ss.77-83, 2021 (ESCI) Sürdürülebilir Kalkınma identifier

Retrospective Analysis of Peripheral T-Cell Lymphoma Patients: Single Center ‘Real-Life’ Experience

Beşışık S., Özbalak M. M., Mastanzade M.
Medical Journal of Bakirkoy , cilt.16, sa.4, ss.1-7, 2020 (ESCI)

Gıda Kaynaklı İmmünomodülatörler

Kohansal Koshksaray F., Özbalak M. M., Balkan İ. İ., Erten Yurdagül G.
Experimed , cilt.10, sa.2, ss.97-111, 2020 (Hakemli Dergi) Sürdürülebilir Kalkınma

Bortezomib induced pulmonary toxicity: a case report and review of the literature

Saglam B., Kalyon H., Ozbalak M. M., Ornek S., Keske S., Tabak L., et al.
AMERICAN JOURNAL OF BLOOD RESEARCH , cilt.10, sa.6, ss.407-415, 2020 (ESCI) Sürdürülebilir Kalkınma identifier

Retrospective Analysis of Peripheral T-Cell Lymphoma Patients: Single Center 'Real-Life' Experience

Ozbalak M. M., MASTANZADE M., Ozluk O., TİRYAKİ T. O., Hindilerden I. Y., YENEREL M. N., et al.
MEDICAL JOURNAL OF BAKIRKOY , cilt.16, sa.4, ss.392-398, 2020 (ESCI) Creative Commons License identifier

Inflammatory myofibroblastic tumor mimicking a relapse in a patient with Hodgkin's lymphoma: report of an unusual case and review of the literature.

Özbalak M. M., Torun E. S., ÖZDEMIRLI M., Uçar A. R., Akpınar T. S., Taşçıoğlu C., et al.
Clinical case reports , cilt.5, ss.945-949, 2017 (ESCI) identifier identifier

Detailed analysis of diffuse large B cell lymphoma patients: a single-center, retrospective study.

Ozbalak M. M., Ar M. C., Tuzuner N., Salihoglu A., Eskazan A. E., Ongoren Aydin S., et al.
ISRN hematology , cilt.2013, ss.908191, 2013 (Hakemli Dergi) Creative Commons License identifier

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Büyük granüllü lenfosit artışı olan olguların tanısında immünfenotiplemenin rolü: Tek merkez deneyimi

NAZLIGÜL SERT E., TİRYAKİ T. O., ÖZBALAK M. M., MASTANZADE M., ÖZLÜK D. Ö., ERDEM S., et al.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 01 Kasım 2022, ss.199-200

Kronik lenfositer lösemi olgularının tanı sırasındaki T lenfosit alt gruplarının prognoz üzerine etkisi

SEYİTHANOĞLU D., NAZLIGÜL SERT E., ERDEM S., ÖZBALAK M. M., MASTANZADE M., ÖZLÜK D. Ö., et al.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 01 Kasım 2022, ss.145-146

Multipl miyelom dışı plazma hücre hastalıklarında kök hücre desteği ile yüksek doz kemoterapi deneyimi

TİRYAKİ T. O., YÖNAL HİNDİLERDEN İ., ERDEM S., MASTANZADE M., ÖZBALAK M. M., OLUK B., et al.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 01 Kasım 2022, ss.196-197

ASPARAGINASE INDUCED SINUS VEIN THROMBOSIS IN AN ADULT YOUNG ALL PATIENT

OLUK B., KUBİLAY D. Ö., ÖZBALAK M. M., ERDEM S., BEŞIŞIK S.
XIIth Eurasian Hematology-Oncology Congress, İSTANBUL (Hibrit Kongre), Türkiye, 10 Kasım 2021, cilt.43, ss.77

WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?

ERDEM S., MASTANZADE M., ÖZBALAK M. M., KUBİLAY D. Ö., TİRYAKİ T. O., OLUK B., et al.
XIIth Eurasian Hematology-Oncology Congress, İSTANBUL (Hibrit Kongre), Türkiye, 10 Kasım 2021, cilt.43, ss.96

Yeni tanı DBBHL’de biyobenzer rituksimab (Redditux) içeren R-CHOP rejimi sonuçları: Tek merkez gerçek yaşam deneyimi

ÖZBALAK M. M., MASTANZADE M., KUBİLAY D. Ö., TİRYAKİ T. O., ERDEM S., Pınar Özbalak E., et al.
47. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 04 Kasım 2021

A Case of Congenital Afibrinogenemia with Two Successful Spontaneous Delivery after Recurrent Pregnancy Losses

Mastanzade M., Özbalak M. M., Beşışık S.
ISTH 2021 Congress, Pennsylvania, Amerika Birleşik Devletleri, 17 - 21 Temmuz 2021, sa.5, ss.312

Increased activity of follicular helper T and cytotoxic T cellsin chronic lymphocytic leukemia

Gelmez M. Y., Öktelik F. B., Çınar S., Özbalak M. M., Deniz G.
6th European Congress of Immunology (ECI 2021), Belgrade, Sırbistan, 1 Eylül - 04 Ekim 2021, ss.1

Increased activity of follicular helper T and follicular cytotoxic T cells in Chronic Lymphocytic Leukemia

Gelmez M. Y., Öktelik F. B., Çınar S., Özbalak M. M., Özlük Ö., Deniz G., et al.
6th European Congress of Immunology, Belgrade, Sırbistan, 1 - 04 Eylül 2021, ss.245

Dual-Beam optical Manipulation of Red blood cells for the investigation of paroxysmal nocturnal hemoglobinuria

Parlatan U., Soysal K. B., Parlatan S., Mastanzade M., Ozbalak M. M., Yenerel M. N., et al.
Optical Manipulation and Its Applications, OMA 2021 - Part of Biophotonics Congress: Optics in the Life Sciences 2021, Virtual, Online, Amerika Birleşik Devletleri, 12 - 16 Nisan 2021 identifier

A raman tweezer study with single red blood cells for the diagnosis of paroxysmal nocturnal hemoglobinuria

Parlatan S., Parlatan U., Soysal K. B., Mastanzade M., Ozbalak M. M., Yenerel M. N., et al.
Optical Molecular Probes, Imaging and Drug Delivery, OMP 2021 - Part of Biophotonics Congress: Optics in the Life Sciences 2021, Virtual, Online, Amerika Birleşik Devletleri, 12 - 16 Nisan 2021 identifier

Prognostic value of pre-treatment neutrophil-lymphocyte and platelet-lymphocyte ratio in diffuse large B-cell lymphoma: a single-center experience

Dağcı G., Mastanzade M., Özbalak M. M., Kubilay D. Ö., Tiryaki T. O., Yönal Hindilerden İ., et al.
XIth Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 21 - 24 Ekim 2020, sa.42, ss.48-49

FUSARİUM SPP İLE SİNOPULMONER İNFEKSİYON: HEMATOLOJİK MALİGNİTELERDE İKİNCİ SIKLIKTA KÜF MANTARI İNFEKSİYONU

ÖZLÜK SEVEN Ö., OLUK B., ÖZBALAK M. M., SOLTANOVA L., ALTUNOK D., YILMAZ E., et al.
46. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 28 - 31 Ekim 2020, ss.177-178

Role of [68Ga]-pentixafor-PET/CT as a novel imaging of cxcr4 expression in multiple myeloma comparison to [18F]-FDG-PET/CT

TİRYAKİ T. O., KUYUMCU S., HAS ŞİMŞEK D., ÖZBALAK M. M., KUBİLAY D. Ö., ÜNAL S. N., et al.
Xth International Eurasian Hematology-Oncology Congress, İstanbul, Türkiye, 8 - 12 Ekim 2019, cilt.85

A relapsed refractory CD30 positive cutaneous anaplastic large cell lymphoma with large B-cell transformation responding to brentuximab vedotin after multiple lines of treatment

Erdem S., Ozbalak M. M., Baykal C., Besisik S.
10th Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 8 - 11 Ekim 2019, cilt.85 identifier

Role of [Ga-68]-pentixafor-PET/CT as a novel imaging of cxcr4 expression in multiple myeloma; comparison to [F-18]-FDG-PET/CT

Tiryaki T. O., Kuyumcu S., Has-Simsek D., Ozbalak M. M., Ozluk D., Unal S., et al.
10th Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 8 - 11 Ekim 2019, cilt.85 identifier

A retrospective analysis of peripheral T-cell lymphoma patients: single-center 'real-life' experience

Ozbalak M. M., Besisik S., Mastanzade M., Ozluk O., Ozmen A., Hindilerden I. Y., et al.
10th Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 8 - 11 Ekim 2019, cilt.85 identifier

Long-Term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-Center Real-Life Experience

Ferhanoglu A. B., ÖZBALAK M. M., SALİHOĞLU A., Soysal T., Karadogan I., Paydas S., et al.
59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, Amerika Birleşik Devletleri, 9 - 12 Aralık 2017, cilt.130 identifier

NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: EXPERIENCE IN TURKEY

Ferhanoglu B., Bekoz H., Karadurmus N., Paydas S., Gulbas Z., Turker A., et al.
22nd Congress of the European-Hematology-Association, Madrid, İspanya, 22 - 25 Haziran 2017, cilt.102, ss.84-85 identifier

IS FDG-PET THE MOST SENSITIVE TOOL TO DIAGNOSE BLEOMYCIN INDUCED PNEUMONITIS IN HODGKIN'S LYMPHOMA?

Ozturk E., Falay O., Bolukbasi Y., Gumu T., Ornek S., ÖZBALAK M. M., et al.
10th International Symposium on Hodgkin Lymphoma, Cologne, Almanya, 22 - 25 Ekim 2016, cilt.101, ss.43 identifier

The comparison of up-front autologous peripheral stem cell transplantation in first remission and long-lasting intensive chemotherapy protocols in highly aggressive non-Hodgkin's lymphomas: Results of a retrospective analysis.

Ozturk M., Ozaydin S., Oyan B., Ozbalak M. M., Arpaci F., Paydas S., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30 identifier

Metrikler

Yayın

55

Atıf (WoS)

155

H-İndeks (WoS)

7

Atıf (Scopus)

148

H-İndeks (Scopus)

6

Açık Erişim

5
BM Sürdürülebilir Kalkınma Amaçları